Based on the latest data from August 2025, CRNC is trading at $10.53, which positions the stock well below the lowest PE boundary of 6.8 times. This indicates the stock is trading in severe undervaluation territory, suggesting potential investment opportunity. The current price represents a dramatic recovery from the extreme lows seen in 2024, when the stock briefly traded as low as $2.77 in September 2024, but still remains significantly undervalued relative to historical PE multiples. Analyzing the historical trend reveals a remarkable valuation journey for CRNC over the past five years. The stock experienced extreme overvaluation during 2020-2021, with prices reaching as high as $120.32 in February 2021, trading well above the highest PE boundary of 346.1 times in the warning zone. This was followed by a dramatic correction throughout 2022-2024, where the stock price collapsed from over $95 in early 2021 to under $3 by mid-2024, moving from severe overvaluation to deep undervaluation. The PE stream boundaries themselves have contracted significantly since 2022, indicating deteriorating earnings fundamentals. The recent recovery from the 2024 lows to current levels around $10.53 suggests the stock may be emerging from its most oversold conditions, though it remains in the undervalued zone, presenting a potential value opportunity for investors willing to bet on the company's fundamental recovery.